NYSE:TFX Teleflex - TFX Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Teleflex Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. $240.80 -3.06 (-1.25%) (As of 01/30/2023 12:42 PM ET) Add Compare Share Share Today's Range$239.32▼$243.2250-Day Range$214.04▼$259.4852-Week Range$182.65▼$356.72Volume49,559 shsAverage Volume325,803 shsMarket Capitalization$11.30 billionP/E Ratio27.61Dividend Yield0.56%Price Target$279.62 ProfileAnalyst RatingsChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability Teleflex MarketRank™ ForecastAnalyst RatingModerate Buy2.50 Rating ScoreUpside/Downside16.1% Upside$279.62 Price TargetShort InterestHealthy2.10% of Shares Sold ShortDividend StrengthWeakBased on Four FactorsSustainability-1.53Upright™ Environmental ScoreNews Sentiment0.54Based on 10 Articles This WeekInsider TradingN/AProj. Earnings Growth3.93%From $12.98 to $13.49 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.47 out of 5 starsMedical Sector181st out of 1,049 stocksSurgical & Medical Instruments Industry19th out of 105 stocks 2.3 Analyst's Opinion Consensus RatingTeleflex has received a consensus rating of Buy. The company's average rating score is 2.50, and is based on 6 buy ratings, 6 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $279.62, Teleflex has a forecasted upside of 16.1% from its current price of $240.80.Amount of Analyst CoverageTeleflex has only been the subject of 3 research reports in the past 90 days. Previous Next 5.0 Short Interest Percentage of Shares Shorted2.10% of the outstanding shares of Teleflex have been sold short.Short Interest Ratio / Days to CoverTeleflex has a short interest ratio ("days to cover") of 2.5, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Teleflex has recently decreased by 17.41%, indicating that investor sentiment is improving significantly. Previous Next 1.7 Dividend Strength Dividend YieldTeleflex has a dividend yield of 0.56%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthTeleflex does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Teleflex is 15.60%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Teleflex will have a dividend payout ratio of 10.08% next year. This indicates that Teleflex will be able to sustain or increase its dividend. Previous Next 3.9 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreTeleflex has received a 53.08% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Wound closure devices", "Surgical clamps", and "Catheters" products. See details.Environmental SustainabilityThe Environmental Impact score for Teleflex is -1.53. Previous Next 2.0 News and Social Media Coverage News SentimentTeleflex has a news sentiment score of 0.54. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.72 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 10 news articles for Teleflex this week, compared to 5 articles on an average week.MarketBeat FollowsOnly 3 people have added Teleflex to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Teleflex insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 1.28% of the stock of Teleflex is held by insiders.Percentage Held by Institutions93.82% of the stock of Teleflex is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 1.9 Earnings and Valuation Earnings GrowthEarnings for Teleflex are expected to grow by 3.93% in the coming year, from $12.98 to $13.49 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Teleflex is 27.61, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 125.40.Price to Earnings Ratio vs. SectorThe P/E ratio of Teleflex is 27.61, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 100.73.Price to Earnings Growth RatioTeleflex has a PEG Ratio of 2.75. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioTeleflex has a P/B Ratio of 3.00. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Teleflex (NYSE:TFX) StockTeleflex, Inc. provides medical technology products which enables healthcare providers to improve patient outcomes and enhance patient and provider safety. The firm designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. It operates through the following business segments: Americas, EMEA (Europe, the Middle East and Africa), Asia (Asia Pacific) and OEM. The Americas segment engages in the sales of interventional urology products. The EMEA engages in the sales of urology products. The Asia segment designs, manufactures and distributes medical devices primarily used in critical care, surgical applications and cardiac care and generally serves hospitals and healthcare providers. The OEM segment designs, manufactures and supplies devices and instruments for other medical device manufacturers. The company was founded in 1943 and is headquartered in Wayne, PA.Read More Receive TFX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Teleflex and its competitors with MarketBeat's FREE daily newsletter. Email Address TFX Stock News HeadlinesJanuary 28, 2023 | americanbankingnews.comTeleflex Incorporated (NYSE:TFX) Receives Average Recommendation of "Moderate Buy" from AnalystsJanuary 28, 2023 | americanbankingnews.comBrokerages Set Teleflex Incorporated (NYSE:TFX) PT at $279.62January 30, 2023 | Porter & Company (Ad)Is This The End of Capitalism?EXPOSED: The establishment plot to disenfranchise and impoverish millions of Americans…January 26, 2023 | finance.yahoo.comThe Zacks Analyst Blog Highlights Comcast, Aon, Trane Technologies, Huntington Bancshares and TeleflexJanuary 25, 2023 | marketwatch.comTeleflex Inc. stock falls Tuesday, underperforms marketJanuary 25, 2023 | marketwatch.comTeleflex Inc. stock outperforms market on strong trading dayJanuary 24, 2023 | americanbankingnews.comReviewing Aethlon Medical (NASDAQ:AEMD) and Teleflex (NYSE:TFX)January 17, 2023 | finance.yahoo.comReturn Trends At Teleflex (NYSE:TFX) Aren't AppealingJanuary 30, 2023 | Investing Trends (Ad)Solar Industry at Start of Long Bull Run?The U.S. solar industry generated nearly $33 billion of private investment in the American economy in 2021 -- and analysts say it looks like the start of a long solar bull market. Leading the way is the just-signed Inflation Reduction Act of 2022. With its generous investment tax credits, the Act is expected to triple U.S. solar energy production over the next 5 years.December 29, 2022 | finance.yahoo.comMedical device maker Teleflex to shutter Pleasanton, Livermore facilitiesDecember 28, 2022 | finance.yahoo.comTeleflex (NYSE:TFX) shareholders have endured a 33% loss from investing in the stock three years agoDecember 27, 2022 | finance.yahoo.comTeleflex to Present at the 41st Annual J.P. Morgan Healthcare ConferenceDecember 15, 2022 | finance.yahoo.comTeleflex Celebrates 400,000 Patients Treated With the Minimally Invasive UroLift® SystemNovember 30, 2022 | finance.yahoo.comIs Teleflex Incorporated (NYSE:TFX) Trading At A 37% Discount?November 28, 2022 | forbes.comShould You Buy Teleflex Stock At $225?November 21, 2022 | finance.yahoo.comTeleflex Earns Top Spot in MedReps Best Places to Work 2023 RankingNovember 16, 2022 | finance.yahoo.comTeleflex to Present at the 34th Annual Piper Sandler Healthcare ConferenceNovember 7, 2022 | finance.yahoo.comInsiders who purchased Teleflex Incorporated (NYSE:TFX) earlier this year lose an additional US$105k as the stock sinks to US$202November 7, 2022 | markets.businessinsider.comTeleflex Expands Recalls Of Gibeck Iso-Gard Filters November 3, 2022 | finance.yahoo.comTeleflex Announces Worldwide Recall of Gibeck® Iso-Gard® FilterNovember 2, 2022 | finance.yahoo.comTeleflex Recalls Respiratory Filters Due To Leakage, Insufficient Air Supply RiskNovember 1, 2022 | finance.yahoo.comTeleflex (TFX) Q3 Earnings Top Estimates, Adjusted EPS View CutNovember 1, 2022 | finance.yahoo.comU.S. FDA classifies recall of Teleflex's respiratory filters as most seriousNovember 1, 2022 | finance.yahoo.comTeleflex to Present at the Jefferies London Healthcare ConferenceOctober 27, 2022 | finance.yahoo.comTeleflex (TFX) Surpasses Q3 Earnings EstimatesOctober 25, 2022 | seekingalpha.comTeleflex: More Constructive Following Recent Weakness, Valuations NoteworthyOctober 25, 2022 | finance.yahoo.comShould You Sell Teleflex Incorporated (TFX)?See More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive TFX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Teleflex and its competitors with MarketBeat's FREE daily newsletter. Email Address TFX Company Calendar Last Earnings10/28/2021Ex-Dividend for 12/15 Dividend11/14/2022Dividend Payable12/15/2022Today1/30/2023Next Earnings (Estimated)2/23/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE Industry Surgical & medical instruments Sub-IndustryHealth Care Equipment SectorMedical Current SymbolNYSE:TFX CUSIP87936910 CIK96943 Webwww.teleflex.com Phone(610) 225-6800Fax215-553-5402Employees14,000Year Founded1943Price Target and Rating Average Stock Price Forecast$279.62 High Stock Price Forecast$400.00 Low Stock Price Forecast$210.00 Forecasted Upside/Downside+16.1%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage12 Analysts Profitability EPS (Most Recent Fiscal Year)$8.72 Trailing P/E Ratio27.61 Forward P/E Ratio18.55 P/E Growth2.75Net Income$485.37 million Net Margins14.76% Pretax Margin17.17% Return on Equity16.26% Return on Assets9.14% Debt Debt-to-Equity Ratio0.41 Current Ratio2.39 Quick Ratio1.52 Sales & Book Value Annual Sales$2.81 billion Price / Sales4.02 Cash Flow$18.42 per share Price / Cash Flow13.07 Book Value$80.15 per share Price / Book3.00Miscellaneous Outstanding Shares46,910,000Free Float46,306,000Market Cap$11.30 billion OptionableOptionable Beta1.04 Social Links Key ExecutivesLiam J. KellyChairman, President & Chief Executive OfficerThomas E. PowellChief Financial Officer & Executive Vice PresidentJustin McMurrayVP-Global Strategic Research & DevelopmentTimothy F. DuffyChief Information Officer & Vice PresidentMichelle FoxChief Medical Officer & Vice PresidentKey CompetitorsGlobus MedicalNYSE:GMEDAbiomedNASDAQ:ABMDIntegra LifeSciencesNASDAQ:IARTInsuletNASDAQ:PODDBaxter InternationalNYSE:BAXView All CompetitorsInsiders & InstitutionsNew York State Teachers Retirement SystemSold 687 shares on 1/27/2023Ownership: 0.112%Natixis Advisors L.P.Bought 5,191 shares on 1/27/2023Ownership: 0.052%Rice Hall James & Associates LLCSold 363 shares on 1/27/2023Ownership: 0.025%Baldwin Brothers LLC MABought 6,915 shares on 1/27/2023Ownership: 0.015%Lapides Asset Management LLCBought 5,700 shares on 1/27/2023Ownership: 0.012%View All Insider TransactionsView All Institutional Transactions TFX Stock - Frequently Asked Questions Should I buy or sell Teleflex stock right now? 12 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Teleflex in the last twelve months. There are currently 6 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" TFX shares. View TFX analyst ratings or view top-rated stocks. What is Teleflex's stock price forecast for 2023? 12 equities research analysts have issued 12-month price objectives for Teleflex's stock. Their TFX share price forecasts range from $210.00 to $400.00. On average, they expect the company's stock price to reach $279.62 in the next year. This suggests a possible upside of 15.8% from the stock's current price. View analysts price targets for TFX or view top-rated stocks among Wall Street analysts. How have TFX shares performed in 2023? Teleflex's stock was trading at $249.63 at the beginning of 2023. Since then, TFX stock has decreased by 3.3% and is now trading at $241.50. View the best growth stocks for 2023 here. Are investors shorting Teleflex? Teleflex saw a drop in short interest during the month of January. As of January 15th, there was short interest totaling 982,800 shares, a drop of 17.4% from the December 31st total of 1,190,000 shares. Based on an average trading volume of 398,100 shares, the short-interest ratio is presently 2.5 days. View Teleflex's Short Interest. When is Teleflex's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, February 23rd 2023. View our TFX earnings forecast. How were Teleflex's earnings last quarter? Teleflex Incorporated (NYSE:TFX) issued its quarterly earnings data on Thursday, October, 28th. The medical technology company reported $3.51 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.03 by $0.48. The medical technology company earned $700.25 million during the quarter, compared to analysts' expectations of $698.25 million. Teleflex had a net margin of 14.76% and a trailing twelve-month return on equity of 16.26%. The business's quarterly revenue was up 11.5% on a year-over-year basis. During the same period last year, the company posted $2.77 EPS. Read the conference call transcript. How often does Teleflex pay dividends? What is the dividend yield for Teleflex? Teleflex announced a quarterly dividend on Thursday, October 27th. Stockholders of record on Tuesday, November 15th will be paid a dividend of $0.34 per share on Thursday, December 15th. This represents a $1.36 annualized dividend and a yield of 0.56%. The ex-dividend date of this dividend is Monday, November 14th. Read our dividend analysis for TFX. Is Teleflex a good dividend stock? Teleflex (NYSE:TFX) pays an annual dividend of $1.36 per share and currently has a dividend yield of 0.56%. The dividend payout ratio is 15.60%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, TFX will have a dividend payout ratio of 10.08% next year. This indicates that the company will be able to sustain or increase its dividend. Read our dividend analysis for TFX. What guidance has Teleflex issued on next quarter's earnings? Teleflex updated its FY 2022 earnings guidance on Thursday, November, 3rd. The company provided earnings per share guidance of $12.80-$13.20 for the period, compared to the consensus EPS estimate of $13.10. The company issued revenue guidance of $2.79 billion-$2.82 billion, compared to the consensus revenue estimate of $2.81 billion. What is Liam Kelly's approval rating as Teleflex's CEO? 73 employees have rated Teleflex Chief Executive Officer Liam Kelly on Glassdoor.com. Liam Kelly has an approval rating of 86% among the company's employees. What other stocks do shareholders of Teleflex own? Based on aggregate information from My MarketBeat watchlists, some companies that other Teleflex investors own include NVIDIA (NVDA), AbbVie (ABBV), Johnson & Johnson (JNJ), Alibaba Group (BABA), Lam Research (LRCX), ServiceNow (NOW), QUALCOMM (QCOM), Advanced Micro Devices (AMD), Salesforce (CRM) and Cisco Systems (CSCO). What is Teleflex's stock symbol? Teleflex trades on the New York Stock Exchange (NYSE) under the ticker symbol "TFX." Who are Teleflex's major shareholders? Teleflex's stock is owned by a variety of retail and institutional investors. Top institutional investors include Allspring Global Investments Holdings LLC (1.71%), Ceredex Value Advisors LLC (0.79%), Villere ST Denis J & Co. LLC (0.42%), Boston Trust Walden Corp (0.31%), Sumitomo Mitsui Trust Holdings Inc. (0.28%) and AMI Asset Management Corp (0.25%). Insiders that own company stock include Andrew A Krakauer, Cameron P Hicks, James J Leyden, John Deren, Liam Kelly, Stephen K MD Klasko, Stephen K MD Klasko and Stuart A Randle. View institutional ownership trends. How do I buy shares of Teleflex? Shares of TFX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Teleflex's stock price today? One share of TFX stock can currently be purchased for approximately $241.50. How much money does Teleflex make? Teleflex (NYSE:TFX) has a market capitalization of $11.33 billion and generates $2.81 billion in revenue each year. The medical technology company earns $485.37 million in net income (profit) each year or $8.72 on an earnings per share basis. How many employees does Teleflex have? The company employs 14,000 workers across the globe. How can I contact Teleflex? Teleflex's mailing address is 550 E SWEDESFORD RD, WAYNE PA, 19087. The official website for the company is www.teleflex.com. The medical technology company can be reached via phone at (610) 225-6800, via email at shareholder@broadridge.com, or via fax at 215-553-5402. This page (NYSE:TFX) was last updated on 1/30/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.